Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula (RAP)

Nestlé

Status: Completed

Conditions: Enteral Feeding Intolerance

Treatments: Other: Enteral Formula

Study type: Observational

Funder types: Industry

Identifiers

NCT03048409

16.06.US.HCN

Details and patient eligibility

About

A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing care facility.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• > 18 years of age on admission to facility
• Prescribed enteral nutrition with the goal to provide at least 90% of estimated daily calorie and protein requirements for ≥ 2 weeks prior to switch
• Received enteral nutrition with an intact protein formula for a minimum of three days prior to a switch to a peptide-based formula
• Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a peptide-based formula
• Receiving a peptide-based formula formula for ≥ 2 weeks
• Have documentation of an assessment of feeding tolerance following the switch
• Formulas received must be indicated for use in adults.

Exclusion criteria

• Abdominal surgery (within past 30 days prior to switch)
• Having any infection, including upper respiratory, viral, gastroenteritis,wound infections, c difficile, at time of switch
• Having documented cow's milk protein allergy at time of switch
• Medical records lacking information on rationale for switch to a peptide-based formula and/or response to change (positive, neutral or negative).

Trial design

10 participants in 1 patient group

Enteral tube fed adults

Description:

Enteral formula

Treatment:

Other: Enteral Formula